## Most Common Sphingolipidosis in the Indian Population **Key Point:** **Gaucher disease** is the most common sphingolipidosis (and the most common lysosomal storage disorder overall) in the Indian population, as well as globally. ### Understanding the Clinical Vignette The stem describes a child with: - Neurological decline + hepatosplenomegaly + cherry-red spot → classic features of **Sandhoff disease** - Enzyme deficiency: **Hexosaminidase A AND B** → Sandhoff disease (not Tay-Sachs, which has only Hex-A deficiency) However, the question asks: *"Which is the most common sphingolipidosis in the Indian population?"* — a separate epidemiological question. ### Sphingolipidoses: Comparative Epidemiology | Disorder | Enzyme Deficiency | Substrate | Relative Frequency in India | |----------|-------------------|-----------|----------------------------| | **Gaucher disease** | β-glucocerebrosidase | Glucocerebroside | **Most common sphingolipidosis** | | Tay-Sachs disease | Hexosaminidase A | GM₂ ganglioside | Rare in India; common in Ashkenazi Jews | | Sandhoff disease | Hexosaminidase A & B | GM₂ ganglioside | Rare | | Niemann-Pick disease | Sphingomyelinase | Sphingomyelin | Rare | | Metachromatic leukodystrophy | Arylsulfatase A | Sulfatide | Rare | **High-Yield:** Gaucher disease is the **most common lysosomal storage disorder overall** and the **most common sphingolipidosis** both globally and in India. It is caused by deficiency of β-glucocerebrosidase (acid β-glucosidase), leading to accumulation of glucocerebroside in macrophages of the liver, spleen, and bone marrow. ### Why NOT Tay-Sachs? - Tay-Sachs disease is the most common sphingolipidosis in **Ashkenazi Jewish** populations (carrier frequency ~1 in 30), not in the Indian population. - In India, Tay-Sachs is rare; there is no established epidemiological evidence that it is the most common sphingolipidosis in North India or any Indian ethnic group. - The enzyme deficiency in the stem (Hex-A **and** B) actually describes **Sandhoff disease**, not Tay-Sachs. ### Gaucher Disease: Key Features (Harrison's Principles of Internal Medicine) 1. **Enzyme defect:** β-glucocerebrosidase (GBA gene) 2. **Substrate:** Glucocerebroside accumulates in macrophages ("Gaucher cells" — wrinkled tissue paper appearance) 3. **Types:** - Type 1 (non-neuronopathic): Most common; hepatosplenomegaly, bone disease, cytopenias; NO neurological involvement - Type 2 (acute neuronopathic): Infantile onset, severe CNS involvement, death by age 2 - Type 3 (subacute neuronopathic): Juvenile onset, slower neurological decline 4. **Treatment:** Enzyme replacement therapy (imiglucerase) — available and effective for Type 1 **Clinical Pearl:** Gaucher disease is the most common lysosomal storage disorder worldwide and in India. It should be the first sphingolipidosis considered in any Indian patient presenting with unexplained hepatosplenomegaly and cytopenias. (Reference: Harrison's Principles of Internal Medicine, 21st ed.; Robbins & Cotran Pathologic Basis of Disease, 10th ed.) **Warning:** Do not confuse "most common sphingolipidosis" (Gaucher disease) with "most common sphingolipidosis in Ashkenazi Jews" (Tay-Sachs). The Indian population epidemiology clearly favors Gaucher disease.
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.